All stock lists
Krispy Kreme, Inc. (NASDAQ:DNUT)
US · Delayed Price · Currency is USD
Consumer Defensive · Grocery Stores
4.61+1.09 (+30.89%)
Market cap
$799M
Insider Score
Health Score
Analyst consensus
Listed since
Jul 1, 2021
Website
Insider Score
––Not scored
DNUT Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Weak
From DNUT’s reported statements · Q3 2026 (trailing 12 months)
Profitability7 / 20
Loses money on what it sells.
- Revenue
- $1.42B
- Net income
- -$89.6M
- Net margin
- -6.3%
Leverage0 / 20
Heavily indebted for what it earns.
- Total debt
- $455.5M
- Cash
- $30.3M
- Net debt / EBITDA
- 4.77x
Liquidity0 / 20
Owes more within a year than it holds to pay it.
- Current assets
- $180.9M
- Current liabilities
- $466.8M
- Current ratio
- 0.39
Cash generation13 / 20
Roughly cash-neutral.
- Operating cash flow
- $97.3M
- Free cash flow
- $37.3M
- FCF margin
- 2.6%
Dilution & runway19 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 173.5M
- Share growth (1y)
- 1.4%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
DNUT Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Sep 27, 2026 | Jun 28, 2026 | Mar 29, 2026 | Dec 28, 2025 | Sep 28, 2025 | Jun 29, 2025 |
| Revenue | 328.76 M | 331.00 M | 367.03 M | 392.37 M | 375.30 M | 379.77 M |
| Revenue Growth (YoY) | -12.40 % | -12.84 % | -2.17 % | -2.88 % | -1.20 % | -13.46 % |
| Cost of Revenue | 85.81 M | 86.04 M | 88.33 M | 92.99 M | 96.21 M | 92.63 M |
| Gross Profit | 242.95 M | 244.96 M | 278.70 M | 299.38 M | 279.08 M | 287.14 M |
| SG&A Expense | 54.63 M | 64.78 M | 68.15 M | 65.41 M | 61.19 M | 75.11 M |
| R&D Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 65.42 M | 255.93 M | 282.33 M | 306.65 M | 286.26 M | 721.69 M |
| Operating Income | 177.53 M | -10.98 M | -3.63 M | -7.27 M | -7.18 M | -434.55 M |
| Pretax Income | -22.18 M | -24.09 M | -19.09 M | -24.01 M | -22.95 M | -461.57 M |
| Tax Provision | -8.82 M | -4.26 M | 3.58 M | 5.12 M | -2.82 M | -20.45 M |
| Net Income | -13.36 M | -20.31 M | -28.19 M | -27.78 M | -19.44 M | -435.26 M |
| EPS (Basic) | -0.08 | -0.12 | -0.16 | -0.16 | -0.11 | -2.55 |
| EPS (Diluted) | -0.08 | -0.12 | -0.16 | -0.16 | -0.11 | -2.55 |
| Shares Outstanding | 173.48 M | 172.58 M | 172.02 M | 171.44 M | 171.16 M | 170.80 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.